U.S. Physical Therapy (NYSE:USPH) Share Price Crosses Above 200-Day Moving Average – Should You Sell?

U.S. Physical Therapy, Inc. (NYSE:USPH)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $73.09 and traded as high as $83.35. U.S. Physical Therapy shares last traded at $82.28, with a volume of 169,774 shares changing hands.

Analyst Ratings Changes

USPH has been the subject of several analyst reports. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 19th. Barrington Research increased their price target on U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Zacks Research upgraded U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 27th. Citizens Jmp reaffirmed a “market outperform” rating and issued a $98.00 price objective on shares of U.S. Physical Therapy in a research report on Wednesday, June 24th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $98.25.

U.S. Physical Therapy Trading Down 0.6%

The stock’s 50-day moving average price is $78.52 and its 200 day moving average price is $73.08. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.27 and a quick ratio of 1.27. The firm has a market capitalization of $1.23 billion, a PE ratio of 486.41, a price-to-earnings-growth ratio of 2.09 and a beta of 1.13.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.75 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.06). The firm had revenue of $214.06 million for the quarter, compared to analysts’ expectations of $211.36 million. U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%.The company’s revenue for the quarter was up 8.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.81 earnings per share. On average, sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.89 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 11th. Stockholders of record on Friday, August 21st were paid a dividend of $0.46 per share. The ex-dividend date was Friday, August 21st. This represents a $1.84 annualized dividend and a dividend yield of 2.2%. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 1,082.35%.

Institutional Trading of U.S. Physical Therapy

Hedge funds have recently added to or reduced their stakes in the business. Hantz Financial Services Inc. increased its position in U.S. Physical Therapy by 56.4% during the 4th quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock valued at $29,000 after purchasing an additional 132 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of U.S. Physical Therapy in the 2nd quarter valued at about $30,000. Integrated Wealth Concepts LLC purchased a new stake in shares of U.S. Physical Therapy in the 2nd quarter worth approximately $33,000. Parallel Advisors LLC boosted its stake in shares of U.S. Physical Therapy by 75.2% during the first quarter. Parallel Advisors LLC now owns 785 shares of the company’s stock valued at $59,000 after purchasing an additional 337 shares in the last quarter. Finally, Huntington National Bank boosted its stake in shares of U.S. Physical Therapy by 15.4% during the fourth quarter. Huntington National Bank now owns 1,052 shares of the company’s stock valued at $82,000 after purchasing an additional 140 shares in the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc is a healthcare company that operates outpatient physical therapy clinics and manages physical therapy practices throughout the United States. Its clinics provide rehabilitation services for patients recovering from injuries, surgeries, illnesses and chronic conditions, with treatment commonly focused on restoring mobility, strength and function.

The company operates both physical therapy facilities and physical therapy management partnerships. In addition to traditional outpatient rehabilitation, its services include sports medicine, workers’ compensation care and related programs designed to help employers prevent and manage workplace injuries.